Search Results Archives: June 2019

June 27, 2019

The Trump administration is quietly helping people get kidneys

From: Vox

Two new rules could make sure more kidneys go to recipients who need them.

June 21, 2019

Key Trump proposal to lower drug prices takes step forward

From: The Hill


The Department of Health and Human Services (HHS) sent to the White House for review a proposal to lower certain drug prices in Medicare by linking them to the lower prices paid in other countries, an idea called the international pricing index.


It is unclear how long the process of White House review will take, and whether the White House will seek to make significant changes to the proposal

Read Complete Article

June 17, 2019

Federal Government Violated The Law In Marijuana Scheduling Evaluation, Group Says

Editor’s Note: For a history of the use of the DQA to seek relief from federal dissemination of inaccurate information concerning the medical use of cannabis, see Americans for Safe Access Data Quality Act Briefs and Replies. To see the power of the DQA to change a DEA scheduling decision, see Jim Tozzi’s Role in Stopping the DEA from Classifying Drug in Schedule 1 Status.

From: Marijuana Moment


June 11, 2019

OMB Reviewing OIG Proposed Rule Amending Federal Anti-kickback and Beneficiary Inducement Policies to Promote Value-Based Care

From: Lexology

Elizabeth B. Carder-Thompson and Debra A. McCurdy | Reed Smith LLP

The White House Office of Management and Budget (OMB) is reviewing a long-awaited Trump Administration proposed rule to amend the safe harbors to the Anti-Kickback Statute (AKS) and exceptions to the beneficiary inducement provisions of the Civil Monetary Penalty (CMP) statute to better support coordinated care. The proposed rule presumably builds on the related request for information (RFI) on this topic issued by the Office of Inspector General (OIG) of the Department of Health Human Services (HHS) in August 2018. As discussed in a Reed Smith client alert, the RFI sought information on, among other things, changes needed in current safe harbors and beneficiary inducement CMPs to promote beneficial care coordination, patient engagement, and value-based arrangements.